189 related articles for article (PubMed ID: 23949688)
1. Combined excision, cryotherapy, and intraoperative mitomycin C (EXCRIM) for localized intraepithelial and squamous cell carcinoma of the conjunctiva.
Sarici AM; Arvas S; Pazarli H
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2201-4. PubMed ID: 23949688
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
[TBL] [Abstract][Full Text] [Related]
3. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
Zaki AA; Farid SF
Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision.
Hanada K; Nishikawa N; Miyokawa N; Yoshida A
Int Ophthalmol; 2017 Feb; 37(1):71-78. PubMed ID: 27061904
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
Bahrami B; Greenwell T; Muecke JS
Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
[TBL] [Abstract][Full Text] [Related]
6. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
[TBL] [Abstract][Full Text] [Related]
7. Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma.
Sugandhi P; George RE
Cornea; 2011 Apr; 30(4):486; author reply 486-7. PubMed ID: 21107255
[No Abstract] [Full Text] [Related]
8. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
Kim BH; Kim MK; Wee WR; Oh JY
Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080
[TBL] [Abstract][Full Text] [Related]
9. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
[TBL] [Abstract][Full Text] [Related]
11. Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
Galor A; Karp CL; Oellers P; Kao AA; Abdelaziz A; Feuer W; Dubovy SR
Ophthalmology; 2012 Oct; 119(10):1974-81. PubMed ID: 22704832
[TBL] [Abstract][Full Text] [Related]
12. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
Rudkin AK; Dempster L; Muecke JS
Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
[TBL] [Abstract][Full Text] [Related]
13. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C.
Nemet AY; Sharma V; Benger R
Clin Exp Ophthalmol; 2006; 34(4):375-7. PubMed ID: 16764660
[TBL] [Abstract][Full Text] [Related]
14. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
Lee JH; Kim YH; Kim MS; Kim EC
Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714
[TBL] [Abstract][Full Text] [Related]
15. Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C.
Birkholz ES; Goins KM; Sutphin JE; Kitzmann AS; Wagoner MD
Cornea; 2011 Jan; 30(1):37-41. PubMed ID: 20861726
[TBL] [Abstract][Full Text] [Related]
16. Treatment of ocular surface squamous neoplasia with Mitomycin C.
Gupta A; Muecke J
Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia.
Chen C; Louis D; Dodd T; Muecke J
Br J Ophthalmol; 2004 Jan; 88(1):17-8. PubMed ID: 14693762
[TBL] [Abstract][Full Text] [Related]
18. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation.
Siganos CS; Kozobolis VP; Christodoulakis EV
Cornea; 2002 Jan; 21(1):12-6. PubMed ID: 11805500
[TBL] [Abstract][Full Text] [Related]
19. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
Shields CL; Naseripour M; Shields JA
Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
[TBL] [Abstract][Full Text] [Related]
20. Surgical excision, cryotherapy, autolimbal transplantation and mitomycin-C in treatment of conjunctival-corneal intraepithelial neoplasia.
Doganay S; Er H; Tasar A; Gürses I
Int Ophthalmol; 2005; 26(1-2):53-7. PubMed ID: 16779567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
